UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nonpeptidic Delta (δ) Opioid Agonists and Antagonists of the Diarylmethylpiperazine Class: What Have We Learned?

Chemistry of Opioids, 2011-01, Vol.299, p.121-140

2011

Volltextzugriff (PDF)

Association of partial systemic exposure and abuse potential for opioid analgesics with abuse deterrence labeling claims supporting product-specific guidance

EClinicalMedicine, 2021-11, Vol.41, p.101135-101135, Article 101135

2021

Volltextzugriff (PDF)

Considerations in assessing the abuse potential of psychedelics during drug development

Neuropharmacology, 2023-02, Vol.224, p.109352, Article 109352

2023

Volltextzugriff (PDF)

A regulatory perspective on the evaluation of hallucinogen drugs for human use

Neuropharmacology, 2018-11, Vol.142, p.135-142

2018

Volltextzugriff (PDF)

A regulatory perspective on the abuse potential evaluation of novel stimulant drugs in the United States

Neuropharmacology, 2014-12, Vol.87, p.97-103

2014

Volltextzugriff (PDF)

Risk based in vitro performance assessment of extended release abuse deterrent formulations

International journal of pharmaceutics, 2016-03, Vol.500 (1-2), p.255-267

2016

Volltextzugriff (PDF)

Concentration-Response Model of Immediate Release Oxycodone Drug Liking by Different Routes of Abuse

Pain medicine (Malden, Mass.), 2022-07, Vol.23 (7), p.1311-1322

2022

Volltextzugriff (PDF)

Current thinking on the premarketing evaluation of abuse-deterrent opioid formulations

Drug and alcohol dependence, 2014-07, Vol.140, p.e24-e24

2014

Volltextzugriff (PDF)

Considerations on designs of intranasal studies for abuse-deterrent products

Drug and alcohol dependence, 2015-11, Vol.156, p.e41-e42

2015

Volltextzugriff (PDF)

Regulatory challenges in evaluating the abuse deterrent properties of novel opioid products

Drug and alcohol dependence, 2015-11, Vol.156, p.e34-e34

2015

Volltextzugriff (PDF)

FDA abuse-deterrent guidance. Assessing new technologies

Drug and alcohol dependence, 2015-01, Vol.146, p.e236-e237

2015

Volltextzugriff (PDF)

Probes for Narcotic Receptor Mediated Phenomena. 19. Synthesis of (+)-4-[(.alpha.R)-.alpha.-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): A Highly Selective, Nonpeptide .delta. Opioid Receptor Agonist

Journal of medicinal chemistry, 1994-07, Vol.37 (14), p.2125-2128

1994

Volltextzugriff (PDF)

Chemistry of Opioids

Nagase, Hiroshi

1, 2011

Volltextzugriff (PDF)

Probes for Narcotic Receptor Mediated Phenomena. 23. Synthesis, Opioid Receptor Binding, and Bioassay of the Highly Selective δ Agonist (+)-4-[(αR)-α-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and Related Novel Nonpeptide δ Opioid Receptor Ligands

Journal of medicinal chemistry, 1997-02, Vol.40 (5), p.695-704

1997

Volltextzugriff (PDF)

Probes for Narcotic Receptor Mediated Phenomena. 26. − Synthesis and Biological Evaluation of Diarylmethylpiperazines and Diarylmethylpiperidines as Novel, Nonpeptidic δ Opioid Receptor Ligands

Journal of medicinal chemistry, 1999-12, Vol.42 (26), p.5455-5463

1999

Volltextzugriff (PDF)

Novel 1-Phenylcycloalkanecarboxylic Acid Derivatives Are Potent and Selective .sigma.1 Ligands

Journal of medicinal chemistry, 1994-07, Vol.37 (15), p.2285-2291

1994

Volltextzugriff (PDF)

Rat natural killer cell, T cell and macrophage functions after intracerebroventricular injection of SNC 80

The Journal of pharmacology and experimental therapeutics, 1998-08, Vol.286 (2), p.931

1998

Volltextzugriff (PDF)

Assessment of SNC 80 and Naltrindole Within a Conditioned Taste Aversion Design

Pharmacology, biochemistry and behavior, 2000-08, Vol.66 (4), p.779-787

2000

Volltextzugriff (PDF)

Probes for Narcotic Receptor-Mediated Phenomena. 25. Synthesis and Evaluation of N-Alkyl-Substituted (α-Piperazinylbenzyl)benzamides as Novel, Highly Selective δ Opioid Receptor Agonists

Journal of medicinal chemistry, 1997-08, Vol.40 (18), p.2936-2947

1997

Volltextzugriff (PDF)

Opioid peptide receptor studies. 9. Identification of a novel non-μ- non-δ-like opioid peptide binding site in rat brain

Peptides (New York, N.Y. : 1980), 1998-01, Vol.19 (6), p.1079-1090

1998

Volltextzugriff (PDF)

Novel 1-phenylcycloalkanecarboxylic acid derivatives as potential anticonvulsant agents

Journal of medicinal chemistry, 1991-11, Vol.34 (11), p.3159-3164

1991

Volltextzugriff (PDF)

Unexpected regioselectivity in the lithiation of fluoroanisoles

Journal of organic chemistry, 1988-07, Vol.53 (14), p.3145-3147

1988

Volltextzugriff (PDF)

Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors

The Journal of pharmacology and experimental therapeutics, 1996-06, Vol.277 (3), p.1284

1996

Volltextzugriff (PDF)

The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists

Molecular pharmacology, 1996-12, Vol.50 (6), p.1619-1624

1996

Volltextzugriff (PDF)

Rapid in vivo metabolism of a methylether derivative of (+/-)-BW373U86: the metabolic fate of [3H]SNC121 in rats

The Journal of pharmacology and experimental therapeutics, 1996-12, Vol.279 (3), p.1069

1996

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(60)
Bücher
(2)

Sprache

Englisch
(61)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nonpeptidic Delta (δ) Opioid Agonists and Antagonists of the Diarylmethylpiperazine Class: What Have We Learned?

Association of partial systemic exposure and abuse potential for opioid analgesics with abuse deterrence labeling claims supporting product-specific guidance

Considerations in assessing the abuse potential of psychedelics during drug development

A regulatory perspective on the evaluation of hallucinogen drugs for human use

A regulatory perspective on the abuse potential evaluation of novel stimulant drugs in the United States

Risk based in vitro performance assessment of extended release abuse deterrent formulations

Concentration-Response Model of Immediate Release Oxycodone Drug Liking by Different Routes of Abuse

Current thinking on the premarketing evaluation of abuse-deterrent opioid formulations

Considerations on designs of intranasal studies for abuse-deterrent products

Regulatory challenges in evaluating the abuse deterrent properties of novel opioid products

FDA abuse-deterrent guidance. Assessing new technologies

Probes for Narcotic Receptor Mediated Phenomena. 19. Synthesis of (+)-4-[(.alpha.R)-.alpha.-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): A Highly Selective, Nonpeptide .delta. Opioid Receptor Agonist

Chemistry of Opioids

Probes for Narcotic Receptor Mediated Phenomena. 26. − Synthesis and Biological Evaluation of Diarylmethylpiperazines and Diarylmethylpiperidines as Novel, Nonpeptidic δ Opioid Receptor Ligands

Novel 1-Phenylcycloalkanecarboxylic Acid Derivatives Are Potent and Selective .sigma.1 Ligands

Rat natural killer cell, T cell and macrophage functions after intracerebroventricular injection of SNC 80

Assessment of SNC 80 and Naltrindole Within a Conditioned Taste Aversion Design

Probes for Narcotic Receptor-Mediated Phenomena. 25. Synthesis and Evaluation of N-Alkyl-Substituted (α-Piperazinylbenzyl)benzamides as Novel, Highly Selective δ Opioid Receptor Agonists

Opioid peptide receptor studies. 9. Identification of a novel non-μ- non-δ-like opioid peptide binding site in rat brain

Novel 1-phenylcycloalkanecarboxylic acid derivatives as potential anticonvulsant agents

Unexpected regioselectivity in the lithiation of fluoroanisoles

Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors

The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists

Rapid in vivo metabolism of a methylether derivative of (+/-)-BW373U86: the metabolic fate of [3H]SNC121 in rats

Suchergebnisse filtern